Home / About

RMBC Offer 2008

RMBC is going on with expanding its product and service portfolios under the project "RETAIL AUDIT OF DRUGS IN RF". Approved by AIPM and audited by Deloitte & Touche, the ever efficient methodology of data collection and analysis as well as the variety of available services make it possible for us to implement new options serving our clients:

• Updating of drug audit data in standard products: 1 month after the end of the reporting period.
• The pharmacy panel for standard reports on separate regions and cities was expanded to include 52 regional units. Data collection for other cities is possible on an individual basis.
• Statistical reports on the pharmaceutical markets of CIS (Ukraine, Belarus, Kazakhstan and Uzbekistan).
• New: audit of drugs dispensed to beneficiaries under the DLO program (state drug reimbursement program for vulnerable social groups).
• Program software with a single interface that allows for really quicker data processing, extends and facilitates database report formation and contains a variety of in-built parameters to analyze the pharma-market figures:
  • sales volumes in "units of account" (single dosage/smallest package)
  • drug purchase index (calculation of drug presence in the assortment of pharmacies in the total panel/in the total purchases of pharmacies)
  • drug sales in DDD
  • market split into original and generic drugs (on the basis of patents terms; the data on new drugs on the market is taken from open sources)

RMBC offers an integrated support to its clients and supplements the drug audit package with the following options: